Features
Comprehensive data for every valuation approach.

Features
Benefit from multiples based on the latest available annual financial statements, precisely aligned with the valuation date. This provides a robust historical foundation for your valuation.
Features
Utilize forward-looking multiples based on consensus estimates from experienced analysts. This integrates current market expectations and future perspectives into your valuation.
Features
Revenue, EBITDA, and EBIT Multiples – Flexible for Every Case.
Choose from various financial metrics, available as trailing and forward-looking variants. This allows you to flexibly adapt your analysis to the requirements of your valuation project.
Features
Evaluate the market price of the stock in relation to earnings per share – a proven tool for quick and informed assessments
Features
Price-to-book Ratio (P/B) – Focusing on Substance Value.
Compare the stock price with the book value per share to support substance-oriented valuation approaches
Features
Track the development of multiples over time and place current values in historical context – for informed and understandable valuations
Features
Quality of Analyst Estimates – Assess Reliability.
Obtain detailed information on the number and dispersion of analyst estimates to better assess the reliability of forward-looking multiples



















